Comply With Plasma Testing Requirements
Regulatory agencies require plasma screening for five pathogens—HIV, HBV, HCV, HAV, and Parvo B19—before fractionation. Plasma should also be free of irregular antibodies and have acceptable Anti-A and Anti-B titers to prevent hemolytic events in patients infused with IVIGs.
Enhance Screening Results With Grifols
Grifols instruments help plasma-screening laboratories improve safety by detecting and excluding donations containing pathogens and irregular antibodies from entering manufacturing pools. Our products also reduce learning curves and improve efficiency, ensuring reliable results while reducing costs.
Plasma Solutions Portfolio
Grifols Plasma Testing Portfolio
View our comprehensive portfolio of products and services for plasma donation screening and donor typing. Grifols offers fully automated, flexible solutions for nucleic acid technology (NAT) and irregular antibody screening.
Contact Us to Get StartedRequest your virtual meeting with a workflow expert to take advantage of our consulting services. |
Learn More About Plasma Solutions
This information is intended for physicians and healthcare professionals only.
Product registration and availability vary by country. For more information on product availability, please contact us here.